Literature DB >> 4149419

Tetrahydrocannabinol metabolism in man.

L Lemberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4149419

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  4 in total

1.  Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

Authors:  Linda E Klumpers; Tim L Beumer; Johan G C van Hasselt; Astrid Lipplaa; Lennard B Karger; H Daniël Kleinloog; Jan I Freijer; Marieke L de Kam; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 2.  Therapeutic potential of cannabinoids in CNS disease.

Authors:  J Ludovic Croxford
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

Authors:  E Johansson; M M Halldin; S Agurell; L E Hollister; H K Gillespie
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Multi-laboratory validation of a Δ9-tetrahydrocannabinol LC-MS/MS test kit designed for quantifying THC and marijuana metabolites in blood.

Authors:  Amy L Patton; Joseph O Jones; Anne Nord; D W Eversole; Erin E Feazell; Kristen Mauldin; Lingyun Li; Lee D Williams; Shasha Bai; Kermit Channell; Gregory Endres; Matthew Gamette; Jeffery H Moran
Journal:  Forensic Sci Criminol       Date:  2018-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.